Suppr超能文献

实体器官移植受者脓毒症的生存结局。

Survival Outcome of Sepsis in Recipients of Solid Organ Transplant.

机构信息

Transplant Infectious Diseases Program, University of Nebraska Medical Center, Omaha, Nebraska.

Transplant Surgery Program, University of Nebraska Medical Center, Omaha, Nebraska.

出版信息

Semin Respir Crit Care Med. 2021 Oct;42(5):717-725. doi: 10.1055/s-0041-1735150. Epub 2021 Sep 20.

Abstract

Sepsis is a complex disease stemming from a dysregulated immune response toward an infectious agent. In transplantation, sepsis remains one of the leading causes of morbidity and mortality. Solid organ transplant recipients have impaired adaptive immunity due to immunosuppression required to prevent rejection. Immunosuppression has unintended consequences, such as increasing the risk of infections and sepsis. Due to its high morbidity and mortality, early detection of sepsis is paramount to start aggressive treatment. Several biomarkers or combination of biomarkers of sepsis have emerged in the last decade, but they are not dependable for early diagnosis or for outcome prognosis.

摘要

脓毒症是一种复杂的疾病,源于对感染因子的免疫反应失调。在移植领域,脓毒症仍然是发病率和死亡率的主要原因之一。由于需要免疫抑制来预防排斥反应,实体器官移植受者的适应性免疫受到损害。免疫抑制有一些意外的后果,例如增加感染和脓毒症的风险。由于其高发病率和死亡率,早期发现脓毒症对于开始积极治疗至关重要。过去十年中出现了几种脓毒症的生物标志物或生物标志物组合,但它们不能可靠地用于早期诊断或预后。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验